奥麦罗制药 OMER 深 沪
已收盘 11-14 16:00:00 美东时间
7.87
+1.590
+25.32%
华盛通- 最 高7.89
- 今 开6.64
- 成交量 481.98万股
- 最 低 6.59
- 昨 收 6.28
- 总市值 5.36亿
- 52周最高 13.60
- 市盈率 静 --
- 换手率 7.08%
- 52周最低 2.95
- 委 比 -83.16%
- 总股本 6805.58万
- 历史最高 30.23
- 量 比 3.56
- 振 幅 20.70%
- 历史最低 0.92
- 每 手 1
- 风险率 2.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Figure Technology Stock Is Soaring: What's Going On?
Figure Technology Solutions Inc (NYSE:FIGR) shares are rising today after the company released its third-quarter fiscal report with higher than expected financial results.
11-15 03:47
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling more than 500 points o...
11-14 22:54
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Shares of RLX Technology Inc – ADR (NYSE:RLX) rose sharply in pre-market tradin...
11-14 18:52
Omeros Q3 Adj. EPS $(0.34) Beats $(0.45) Estimate
Omeros (NASDAQ:OMER) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.45) by 23.6 percent. This is a 46.88 percent increase over losses of $(0.64) per share from the same
11-14 05:28
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
Examining the Future: Omeros's Earnings Outlook
Omeros (NASDAQ:OMER) is preparing to release its quarterly earnings on Thursday...
11-12 23:02
Novo Nordisk Q3 Earnings Preview: New CEO, Board Overhaul — Can the U.S. Weight-Loss Market Turn Around?
TradingKey - Novo Nordisk (NVO), one of Europe’s pharmaceutical giants and a leader in the weight-loss drug race, will report its Q3 2025 earnings before market open on November 5. Wall Street expects a modest rebound from Q2’s worst growth in four years, but significant pressure on profits remains.
11-04 10:56
美股牛股 | 奥麦罗制药隔夜暴涨154.2%！与诺和诺德达成重要战略合作；AI服务供应商VERI涨53.7%
奥麦罗制药隔夜暴涨154.2%！与诺和诺德达成重要战略合作；AI服务供应商VERI涨53.7%，预订量激增及Q3业绩好于预期>>
10-16 15:09
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
51:44，共和党临时拨款法案未能获得推进！政府“停摆”已两周，美国用80亿美元研发经费发军饷，关键数据推迟发布，金价继续涨
每经编辑｜程鹏 美东时间周三，受摩根士丹利和美国银行等金融巨头强劲财报推动，标普500指数在震荡中收高。与此同...
10-16 09:00
